In recent weeks we’ve seen Biogen’s CSO exit under pressure and senior marketing execs leave in an exodus as the company recoiled from a fierce backlash against the FDA’s ultra controversial approval of Aduhelm for Alzheimer’s. Now 2 longtime board members are on the way out as well as aftershocks…… Click here to view original post… […]
Moderna Inc. has finally won full U.S. approval for its Covid-19 vaccine, 13 months and 13 days after the FDA first authorized it for emergency use. Click here to view original post… […]
Mount Auburn Hospital in Cambridge has appointed a new president after six months of being led by an interim. Click here to view original post… […]
Two Biogen board members depart as company struggles to get Aduhelm off the ground
fkansteiner
Mon, 01/31/2022 – 10:30
Click here to view original post… […]
It’s almost like Massachusetts has too many biotechs.The industry is hotter than ever, with companies routinely raising millions of dollars in venture capital, startups blooming on a weekly basis, and developers planning more lab space […]
CAMBRIDGE, Mass.: CAMBRIDGE, Mass., Jan. 31, 2022 /PRNewswire/ — NeuroSense Therapeutics Ltd. (Nasdaq: NRSN) ("NeuroSense"), a company developing treatments for severe neurodegenerative diseases, today announced that Alon Ben-Noon, NeuroSenses’s CEO will present a company overview at the BIO CEO & Investor Conference on February 15th at 9:30AM Eastern. The conference… Click here to view original post… […]
WOBURN, Mass. & MIAMI–(BUSINESS WIRE)–Comera Life Sciences, Inc. (“Comera” or the “Company”), which is developing a new generation of bio-innovative biologic medicines to improve patient access, safety, and convenience, and OTR Acquisition Corp. (Nasdaq: OTRAU, OTRA and OTRAW) (collectively referred herein as “OTR”), a publicly traded special purpose acquisition company… Click here to view original post… […]
CAMBRIDGE, Mass.: CAMBRIDGE, Mass., Jan. 31, 2022 /PRNewswire/ — Leica Biosystems, a cancer diagnostics company, has entered into an agreement with Leap Therapeutics (NASDAQ: LPTX), a biotechnology company, to develop a companion diagnostic to detect Dickkopf-related protein 1 (DKK1). The assay will be used to support clinical development of Leap… Click here to view original post… […]
Mass General Brigham and the New Commonwealth Fund are joining together for a $2.5 million statewide initiative to invest in maternal health equity. Click here to view original post… […]
Research Roundup: January 28, 2022 Click here to view original post… […]
Copyright © 2022 Biotech Networks, LLC
